MPT
Medical Properties Trust, Inc.
NYSE · Financial Services · REIT - Industrial · US
$4.01
−0.74%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.0B | 972.0M | 995.5M | 871.8M | 1.5B |
| Cost of Revenue | 178.6M | 36.4M | 27.3M | 41.6M | 45.7M |
| Gross Profit | 840.6M | 935.6M | 968.3M | 830.2M | 1.5B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 129.3M | 130.4M | 133.8M | 145.6M | 160.5M |
| General & Admin Expense | 129.3M | 130.4M | 133.8M | 145.6M | 160.5M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 134.4M | 265.4M | 447.7M | 603.4M | 333.0M |
| Total Operating Expenses | 263.7M | 395.8M | 581.4M | 748.9M | 493.5M |
| Cost and Expenses | 442.2M | 432.2M | 608.7M | 790.5M | 539.2M |
| Operating Income (EBIT) | 577.0M | 539.8M | 386.8M | 81.3M | 1.0B |
| Non-Operating | |||||
| Interest Income | 20.0M | 39.7M | — | — | — |
| Interest Expense | 646.6M | 510.4M | 422.1M | 410.9M | 368.5M |
| Net Interest Income | (626.5M) | (470.6M) | (422.1M) | (410.9M) | (368.5M) |
| Other Non-Op Income/Expense | (609.4M) | (777.1M) | (2.8B) | (768.1M) | (44.0M) |
| Non-Operating Income (excl Interest) | (192.4M) | 266.7M | 2.3B | 357.2M | (324.5M) |
| EBT (Pre-Tax Income) | (32.4M) | (237.3M) | (2.4B) | (686.8M) | 959.7M |
| Income Tax Expense | (3.4M) | 38.6M | 44.1M | (130.7M) | 55.9M |
| Bottom Line | |||||
| Net Income | (30.2M) | (277.0M) | (2.4B) | (556.5M) | 902.6M |
| Earnings from Cont. Ops | (29.0M) | (275.9M) | (2.4B) | (556.1M) | 903.8M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (31.1M) | (277.9M) | (2.4B) | (558.1M) | 901.0M |
| Per Share | |||||
| Basic EPS | ($0.05) | ($0.46) | ($4.02) | ($0.93) | $1.50 |
| Diluted EPS | ($0.05) | ($0.46) | ($4.02) | ($0.93) | $1.50 |
| Revenue Per Share | $1.70 | $1.62 | $1.66 | $1.46 | $2.58 |
| Shares | |||||
| Basic Shares Outstanding | 598.0M | 600.9M | 600.3M | 598.5M | 598.6M |
| Diluted Shares Outstanding | 598.0M | 600.9M | 600.3M | 598.5M | 598.8M |
| Profitability Metrics | |||||
| EBITDA | 1.1B | 545.9M | (1.5B) | 340.2M | 1.7B |
| D&A | 281.9M | 272.8M | 453.7M | 616.1M | 345.6M |
| EBIT | 769.4M | 273.0M | (1.9B) | (275.9M) | 1.3B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026